Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT

Relapse was the major cause of treatment failure in patients with acute lymphoblastic leukemia (ALL) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We aimed to identify the efficacy and safety of preemptive interferon-α (IFN-α) treatment in ALL patients who had minimal residua...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Liu, Sining, Luo, Xueyi, Zhang, Xiaohui, Xu, Lanping, Wang, Yu, Yan, Chenhua, Chen, Huan, Chen, Yuhong, Han, Wei, Wang, Fengrong, Wang, Jingzhi, Liu, Kaiyan, Huang, Xiaojun, Mo, Xiaodong
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677364/
https://ncbi.nlm.nih.gov/pubmed/33214615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-77186-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars